-
1
المؤلفون: N Reinmuth, M L Johnson, B C Cho, A Luft, J A Alatorre-Alexander, S L Geater, K Laktionov, A Vasilyev, D Trukhin, S W Kim, G Ursol, M Hussein, F L Lim, C T Yang, L H Araujo, H Saito, X Shi, L Poole, S Peters, E B Garon, T Mok, J Rawluk
المصدر: 62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V..
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6d3c2c61bcaaa192db5ae5fcd467a2ac
https://doi.org/10.1055/s-0042-1747796 -
2
المؤلفون: Carolyn D. Britten, E. B. Garon, Rashmi Chugh, M. A. Lee, Douglas O. Clary, S. C. Robertson, B. Cancilla, David Smith, Gordana Vlahovic, Herbert Hurwitz
المصدر: Journal of Clinical Oncology. 28:3105-3105
مصطلحات موضوعية: Cancer Research, ABL, Kinase, business.industry, medicine.drug_class, Protein kinase inhibitor, medicine.disease, Phase i study, Oncology, hemic and lymphatic diseases, Maximum tolerated dose, Cancer research, Medicine, In patient, business, Multiple myeloma, Insulin-like growth factor 1 receptor
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::52b7dfb0e572f2c54ff13e07cc7ffaed
https://doi.org/10.1200/jco.2010.28.15_suppl.3105